Cardiology Devices
•31 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (31)
| Company | Market Cap | Price |
|---|---|---|
|
JNJ
Johnson & Johnson
Abiomed's Impella heart pumps are cardiology devices used in interventional workflows.
|
$454.86B |
$188.88
-0.09%
|
|
ABT
Abbott Laboratories
Abbott's cardiology device portfolio includes leadless pacemakers (AVEIR), MitraClip/TMVR systems and other interventional devices, representing core revenue drivers in Cardiology Devices.
|
$215.16B |
$123.64
-0.83%
|
|
BSX
Boston Scientific Corporation
Directly sells Cardiology Devices (e.g., WATCHMAN LAAC, ablation catheters, stents) and other interventional cardiology therapies.
|
$149.01B |
$100.73
+0.16%
|
|
SYK
Stryker Corporation
LIFEPAK 35 defibrillator/monitor aligns with cardiology devices.
|
$136.19B |
$355.94
-3.53%
|
|
MDT
Medtronic plc
Medtronic's core cardiovascular devices include leadless pacing, ablation technologies, and related interventional products.
|
$116.21B |
$90.71
-0.29%
|
|
EW
Edwards Lifesciences Corporation
Core product category including SAPIEN/TAVR, Pascal, Evoque, and SAPIEN M3 used in structural heart interventions.
|
$48.37B |
$82.41
-1.28%
|
|
TFX
Teleflex Incorporated
Cardiology devices (PCI hardware like DCBs and DES) are a primary Teleflex interventional cardiology product area.
|
$5.50B |
$124.49
-0.28%
|
|
MMSI
Merit Medical Systems, Inc.
Directly tied to Merit's core cardiology/interventional devices, including cardiac intervention products and lead-management solutions (Cook acquisition).
|
$5.18B |
$87.48
+5.35%
|
|
LIVN
LivaNova PLC
Core cardiopulmonary hardware including Essenz heart-lung machine and oxygenators.
|
$2.87B |
$52.65
-0.27%
|
|
ITGR
Integer Holdings Corporation
Cardiology devices market, including rhythm management and electrophysiology, is a core high-growth market referenced in the strategy.
|
$2.26B |
$64.53
+1.91%
|
|
AORT
Artivion, Inc.
Includes cardiology devices such as On-X heart valves and other heart/arch repair devices central to Artivion's offerings.
|
$1.94B |
$45.38
-0.59%
|
|
ATRC
AtriCure, Inc.
Core cardiology-focused devices (e.g., AtriClip, EnCompass Clamp, EPi-Sense) are a primary product line for AtriCure.
|
$1.72B |
$34.50
+1.20%
|
|
SSII
SS Innovations International, Inc.
Automated coronary anastomotic connector and cardiology-related robotic devices, categorized under Cardiology Devices.
|
$1.58B |
$8.13
|
|
KMTS
Kestra Medical Technologies, Ltd. Common Stock
Core product is Cardiology devices: wearable defibrillator (ASSURE WCD) and related cardiac therapy platform.
|
$1.41B |
$27.67
-1.05%
|
|
PLSE
Pulse Biosciences, Inc.
Lead cardiac ablation applications (atrial fibrillation) fall under Cardiology Devices.
|
$1.14B |
$16.92
+0.15%
|
|
ANGO
AngioDynamics, Inc.
Cardiology devices applicability given the focus on cardiovascular interventions and related vascular therapies.
|
$488.83M |
$12.04
-0.86%
|
|
AHG
Akso Health Group
Cardiology devices (defibrillators) as part of medical device offerings.
|
$388.28M |
$1.60
-4.29%
|
|
SMLR
Semler Scientific, Inc.
The heart-failure diagnostic extension being pursued places the offering within Cardiology Devices.
|
$295.07M |
$26.52
+7.74%
|
|
CVRX
CVRx, Inc.
Barostim is a cardiology device used to treat heart failure, placing CVRx in the Cardiology Devices category.
|
$265.68M |
$10.18
-4.32%
|
|
STXS
Stereotaxis, Inc.
Catheter-based cardiology devices (ablation/catheters) are a core direct product, fitting Cardiology Devices.
|
$250.26M |
$2.90
-0.86%
|
|
BSGM
BioSig Technologies, Inc.
BioSig's PURE EP Platform has direct cardiology device usage for electrophysiology procedures.
|
$215.15M |
N/A
|
|
AVR
Anteris Technologies Global Corp.
Product category includes cardiology implant devices (heart valves) which AVR is developing and commercializing.
|
$161.92M |
$4.50
+4.29%
|
|
OBIO
Orchestra BioMed Holdings, Inc.
AVIM therapy is an implantable cardiac stimulation-based treatment for hypertension, aligning with Cardiology Devices.
|
$149.42M |
$3.89
-2.99%
|
|
NSPR
InspireMD, Inc.
Carotid stent technology falls under Cardiology Devices / cardiovascular medical devices.
|
$67.70M |
$2.21
+0.91%
|
|
BEAT
HeartBeam, Inc.
HeartBeam targets cardiology devices, namely ECG-based monitoring and diagnostics.
|
$62.54M |
$1.84
+14.29%
|
|
ELUT
Elutia Inc.
Elutia's EluPro is a cardiology device used with cardiac implanted electronic devices (CIEDs), directly tying to Cardiology Devices.
|
$37.39M |
$0.90
-0.69%
|
|
ADGM
Adagio Medical Holdings, Inc.
The vCLAS and related systems target cardiology applications (ventricular tachycardia/atrial fibrillation ablation), placing ADGM in Cardiology Devices.
|
$17.53M |
$1.15
-2.14%
|
|
BCDA
BioCardia, Inc.
Morph DNA is a steerable introducer platform/cardiology device platform that BioCardia is leveraging in the cardiac electrophysiology space.
|
$7.25M |
$1.39
+10.32%
|
|
VASO
Vaso Corporation
Cardiology devices portfolio (EECP systems, Holter monitors, etc.) is a direct product line.
|
$6.87M |
$0.11
|
|
BTCY
Biotricity, Inc.
Core cardiology device portfolio including 3-channel ECG monitoring platforms (Bioflux/Biocore/Biocore Pro).
|
$5.28M |
$0.57
|
|
VTAK
Catheter Precision, Inc.
VTAK's VIVO System is a cardiology-focused medical device for non-invasive 3D mapping, aligning with Cardiology Devices.
|
$1.42M |
$2.45
+2.08%
|
Loading company comparison...
Loading industry trends...
Loading research report...
